SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-057965
Filing Date
2020-12-22
Accepted
2020-12-22 12:32:55
Documents
11
Period of Report
2020-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 4Q 2020 RDO rkda-8k_20201218.htm 8-K 45116
2 EX-4.1 rkda-ex41_21.htm EX-4.1 126922
3 EX-4.2 rkda-ex42_22.htm EX-4.2 127908
4 EX-5.1 rkda-ex51_18.htm EX-5.1 11683
5 EX-10.1 rkda-ex101_19.htm EX-10.1 263332
6 EX-10.2 rkda-ex102_6.htm EX-10.2 465839
7 EX-99.1 rkda-ex991_20.htm EX-99.1 82700
8 GRAPHIC giznewkwdiog000001.jpg GRAPHIC 3626
9 GRAPHIC giznewkwdiog000003.jpg GRAPHIC 6399
10 GRAPHIC giznewkwdiog000002.jpg GRAPHIC 1488
11 GRAPHIC ggaxlbaw4qjy000001.jpg GRAPHIC 7279
  Complete submission text file 0001564590-20-057965.txt   1151203
Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 201406979
SIC: 0100 Agricultural Production-Crops